Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance.
Berckmans Y, Ene HM, Ben-Meir K, Martinez-Conde A, Wouters R, Van den Ende B, Van Mechelen S, Monin R, Frechtel-Gerzi R, Gabay H, Dor-On E, Haber A, Weinberg U, Vergote I, Giladi M, Coosemans A, Palti Y.
Berckmans Y, et al. Among authors: van den ende b.
Front Oncol. 2024 Jun 27;14:1402851. doi: 10.3389/fonc.2024.1402851. eCollection 2024.
Front Oncol. 2024.
PMID: 38993641
Free PMC article.